Overview

Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer

Status:
NOT_YET_RECRUITING
Trial end date:
2026-07-01
Target enrollment:
Participant gender:
Summary
The current study aims to explore the potential advantages of chemotherapy that is implemented based on drug sensitivity testing. This pertains to individuals with locally advanced or metastatic poorly differentiated or anaplastic thyroid cancer who have undergone conventional therapy in the past or unresectable patients .
Phase:
PHASE2
Details
Lead Sponsor:
West China Hospital
Treatments:
Cisplatin
CP protocol
Cyclophosphamide
Docetaxel
Doxorubicin
Gemcitabine
Paclitaxel
TP protocol
Vindesine